Assistant Professor @UWSoN. Nurse scientist in cancer survivorship & cardio-oncology.
Seattle, WA
Joined November 2011
- Tweets122
- Following155
- Followers129
- Likes321
Alexi Vasbinder, PhD, RN retweeted
Celebrating our cardio-onc family at AHA 25 @AartiAsnaniMD @AnaBaracCardio @datsunian @Dr_Mike_Fradley @avirupguha @ACCinTouch @ICOSociety @CleClinicHVTI @CleveClinicFL @Richardkcheng2 @anita_deswal @DrGuptaD @EKoutroumpakis @DrSFeldman
Alexi Vasbinder, PhD, RN retweeted
Dr. Alexi Vasbinder @Avasbind presented "Incidence and Risk Factors of Cardiovascular Events after GvHD among allogeneic SCT recipients." Higher MACE rates seen acute and chronic GvHD.
#ACC25 #CardioOnc
3/10
Alexi Vasbinder, PhD, RN retweeted
Preexisting cardiovascular abnormalities are an important predictor of adverse health outcomes among women with and without cancer in the Women’s Health Initiative. Read more: acsjournals.onlinelibrary.wi…
@OncoAlert @WHIStudy @kerryn_reding @Avasbind @Richardkcheng2 #CardioOncology
Alexi Vasbinder, PhD, RN retweeted
Our new paper in @jitcancer with a group of fine international friends, mentees and colleagues about immunotherapy in patients with cardiac metastasis.
jitc.bmj.com/content/13/3/e0…
@thenasheffect @AminNassarMD @sarahaboualaiwi @TalalZarif1 @DrRanaMcKay @DanaFarber
Alexi Vasbinder, PhD, RN retweeted
New AHA statement published on AI to Enhance Precision Medicine in Cardio-Oncology.
📷 Leveraging artificial intelligence and machine learning in cardio-oncology for precision care.
✍🏼 @rohan_khera @AartiAsnaniMD @md_addison @Avasbind @rimajamal99 @DrTochiOkwuosa
Alexi Vasbinder, PhD, RN retweeted
This statement examines how artificial intelligence (AI) can be utilized to enhance risk prediction models in cardio-oncology, advancing the field toward precision medicine.
✍🏼 @rohan_khera @AartiAsnaniMD @md_addison @Avasbind @rimajamal99 @DrTochiOkwuosa
Alexi Vasbinder, PhD, RN retweeted
@AnaBaracCardio @PennThalheimer @TeresaLpezFdez1 @CathieBiga @DSadlerMD @dineshpmcc1 @md_addison @JacBVo @DarrylLeong @PalaskasN @sarahcud @DrLaCasce AnjuNohria @ACCinTouch @ICOSociety
Alexi Vasbinder, PhD, RN retweeted
Life’s Essential 8 and Incident Cardiovascular Disease in U.S. Women With Breast Cancer – hot off the press ❤️🔥jacc.org/doi/10.1016/j.jacca… led by our stellar IM resident @ElenaWadden @AnaBaracCardio @Avasbind @kerryn_reding @PennThalheimer @fredhutch @UWMedHeart
Alexi Vasbinder, PhD, RN retweeted
Excellent presentation by Dr
@Avasbind Lexi, nursing scientist from the @UWSoN @fredhutch
At the OSU cancer prevention and control research seminar today,
@OSUCCC_James regarding cardio toxicity of cancer therapies
@md_addison #OSU_CardioOncologyProgram
#cancersurvivors
Alexi Vasbinder, PhD, RN retweeted
Out now in JCEM, multicenter study from the International Study of Inflammation in #COVID19, @CardiacLab, @umich exploring the mediating role of #inflammation between obesity and outcomes across the Covid-19 pandemic in 4,644 hospitalized patients. 1/4🧵
academic.oup.com/jcem/articl…
Alexi Vasbinder, PhD, RN retweeted
#ACC24 has started! Phenomenal atmosphere in the Main Tent, Rooms And Posters. Excited to see new #CardioOnc science - it starts with the poster! Congratulations to all presenters and mentors @Avasbind @Richardkcheng2 @GregHundleyMD @datsunian @DocBanks84
Found my #CardioOnc people at #ACC24!
Moderated poster session 'Moving the Frontier of Cardio-Oncology in Breast Cancer🎗' with @datsunian & @DocBanks84.
❤️ hearing about the latest in CardioOnc!
Alexi Vasbinder, PhD, RN retweeted
In a prospective study of @umich Memory and Aging Project, we found that systemic inflammation does NOT significantly predict cognitive decline, challenging assumptions about its role in certain dementias. #suPAR @CardiacLab @avasbind alz-journals.onlinelibrary.w…
Alexi Vasbinder, PhD, RN retweeted
This @AHAScience statement is the result of an effort by a multidisciplinary of adult and pediatric experts from around the nation including #CardioOnc and #Hematology to finally bring you evidence-based guidance on the cardiovascular management of patients undergoing BMT. – at Ann Arbor, MI
Cardiovascular Management of Patients Undergoing Hematopoietic Stem Cell Transplantation: From Pretransplantation to Survivorship #AHAJournals
ahajrnls.org/48OpeaQ
Alexi Vasbinder, PhD, RN retweeted
Hematopoietic stem cell transplantation can cure various disorders but poses CV risks. This new AHA statement summarizes the data on transplant-related complications and provides guidance for CV management throughout the HSCT process.
✍🏽 @salimhayek
🔗 spr.ly/6013XvbHf
Alexi Vasbinder, PhD, RN retweeted
There are no words to Thank You enough, Julia Maues, for empowering the Patient Voice and Inspiring us All! Lets put all the forces to improve Patient-Centered Care @itsnot_pink @FDAOncology @ACCinTouch @ASCOPost @DLMann_MD @PennThalheimer @sdent_duke
Thank you @ACCinTouch and @AnaBaracCardio for bringing us all together for #cardiooncology at #acccardiooncology2024
Nothing better than hearing a patient perspective… after all, that’s #mywhy
Alexi Vasbinder, PhD, RN retweeted
Welcome to the second day of #CardioOnc learning! Inspiring Global community in the Heart House. First session on @FDAOncology by @LalehAmiri @ACCinTouch
Alexi Vasbinder, PhD, RN retweeted
Important Points From #CardioOnc Pre-Con Sessions:
📍Each section within oncology has their own unique needs, cardiotoxicities -- many opportunities to raise awareness of CV care
📍 Mentorship is needed at all stages
📍 Remain humble & resilient
Alexi Vasbinder, PhD, RN retweeted
#CardioOnc Learning started at the Heart House! Grateful for phenomenal community building our actionable knowledge @Richardkcheng2 @CathieBiga @TeresaLpezFdez1 @datsunian @DSadlerMD @anita_deswal @md_arianemacedo @drtarsh
Heading to DC to discuss the care of our cardio-oncology patients -hope to see you there!! Congrats to the incredible planning committee for putting together a stellar line up-Drs Barac, Ky, and the team
@ACCinTouch
Alexi Vasbinder, PhD, RN retweeted
Hello from @CardiacLab @umichCVC! It's been an eventful few months and we're excited to share our research latest updates. Let's dive in: 🧵1/7